Gerresheimer H1 2026 Core Profit Falls on Moulded Glass Weakness

Key Facts

1Drug-packaging maker Gerresheimer reported a lower core profit for the first half of 2026 on Wednesday.

2The performance was weighed down by weakness in the Moulded Glass business and lower demand for injection vials.

Drug-packaging maker Gerresheimer reported a lower core profit for the first half of 2026. Reuters reported that the company's performance missed expectations due to significant weakness within its Moulded Glass business division.

The decline was driven by a reduction in market demand for injection vials, which weighed on the overall financial results for the period. This industrial slowdown occurred as the German Ifo Business Climate index was recorded at 89.9 on September 24, 2026, reflecting the broader environment for manufacturing firms.